Ryan White Care Hepatitis C & B Language
NATAP Webinars
HIV Research Round-Up:
Results from the International AIDS Conference that Matter
Friday, August 23rd, 2024 - 12:30pm
Click here to Register
View all archived NATAP webinars here
Current HIV Articles and News Updates
HIV
CROI:
31st Conference on Retroviruses and Opportunistic Infection
Eric S. Daar, M.D. - Chief, Division of HIV Medicine Harbor-UCLA Medical Center Professor of Medicine David Geffen School of Medicine at UCLA - (03/26/24)
 
IAS:
Antimicrobial resistance (AMR) in Neisseria gonorrhoeae (GC) infections among MSM on Doxycycline post-exposure prophylaxis.
- (07/24/24)
 
IAS:
Performance characteristics of HIV RNA screening with long-acting injectable cabotegravir (CAB-LA) pre-exposure prophylaxis (PrEP) in the multicenter global HIV Prevention Trials Network 083 (HPTN 083) Study
- (07/24/24)
 
IAS:
No Confirmed Virological Failures (CVF) for 144 Weeks When Switching 2-/3-/4-Drug ART to DTG/3TC in Heavily Treatment-Experienced PLWHA with Prior M184V/I and Multiple Virological Failures in the Prospective SOLAR-3D Study
- (07/24/24)
 
More HIV Articles...
Hepatitis D
HEPATITIS D INFECTION: who should be screened AASLD 2018 HBV Guidelines
 
EASL:
Robust reduction of HBsAg and HDV RNA levels with low risk for ALT elevations in JNJ-73763989 treated patients with chronic hepatitis D (CHD) and baseline HBsAg levels below 10,000 IU/mL: Part 2 of the REEF-D study
- (06/18/24)
 
More Hep D Articles...
 
Aging & Perinatally Acquired HIV
 
Incidence of non-AIDS defining comorbidities among young adults with perinatally acquired HIV in North America
- (07/05/24)
 
More Aging & HIV Articles...
 
PrEP
 
The relationship between anti-LGBTQ+ legislation and HIV prevention among sexual and gender minoritized youth
- (05/23/24)
 
More PreP Articles...
Current Hepatitis C and B Articles
Hepatitis C
Medicaid Expansion and Restriction Policies for Hepatitis C Treatment
- (07/20/24)
 
PWH HCV Reinfection Increased as % of New HCV Incidence Despite Decline in Reinfection
- (07/19/24)
 
Estimated Number of People Who Inject Drugs in the United States….and Globally
- (07/11/24)
 
Estimating hepatitis C prevalence in the United States, 2017-2020 - see below, adj. PWD Model 4 million
- (07/11/24)
 
Estimated [UNDER-ESTIMATED] Prevalence and Awareness of Hepatitis C Virus Infection Among US Adults: National Health and Nutrition Examination Survey, January 2017-March 2020 - see full paper below
- (07/09/24)
 
NYS Requires HCV Screening <18> & During Pregnancy; Intensifies HCV Elimination Effort
- (07/09/24)
 
More Hep C Articles...
Hepatitis B
HBV Patient Declaration of Rights
-
 
Long-term Hepatitis B and Liver Outcomes Among Adults Taking Tenofovir-Containing Antiretroviral Therapy for HBV/HIV Coinfection in Zambia - encourages earlier treatment in HBV monoinfection
- (07/10/24)
 
EASL:
Clinical evidence for expanding the treatment guidelines
- (07/04/24)
 
EASL:
Experimental and clinical evidence for expanding HBV treatment guidelines
- (07/04/24)
 
More Hep B Articles...
 
Fatty Liver, NAFLD, NASH
 
Steatotic liver disease and HIV: an agenda for 2030: 'PWH should be screened for fatty liver, steatosis'
- (07/10/24)
 
EASL:
Identification and validation of pre-identified morphological baseline features for prediction of fibrosis progression in MAESTRO-NASH
- (06/18/24)
 
EASL:
Efficacy, tolerability and pharmacokinetics of survodutide, a glucagon/glucagon-like peptide-1 receptor dual agonist, in cirrhosis
- (06/12/24)
 
EASL:
Development and Validation of CLDQ-MASH: A Disease-specific Health-related Quality of Life Instrument for Patients with MASH
- (06/12/24)
 
EASL:
Results from a phase 2a randomized trial with the transglutaminase 2 inhibitor ZED1227 in patients with MASLD
- (06/12/24)
 
EASL:
Week 48 results from the phase 2b ENLIVEN extension study investigating pegozafermin for the treatment of metabolic dysfunction-associated steatohepatitis with fibrosis
- (06/12/24)
 
More Fatty Liver Articles...
Check Out Our Special NATAP Features
List not necessarily listed here in order of date being held.
22 February 2024 - 23 February 2024 Nairobi Kenya
https://academicmedicaleducation.com/meeting/african-workshop-hiv-women-2024
May 2-4, 2024 Atlanta, GA
https://acthiv.org/acthiv-2024-program/
https://ddw.org/
https://easl.eu/event/easl-congress-2024/
https://asm.org/Events/ASM-Microbe/Home
Munich, Germany, and virtually from 22 to 26 July 2024.
Pre-conferences will be held on 20 and 21 July.
https://www.iasociety.org/conferences/aids2024
Conference on Liver Disease in Africa (COLDA) 2024
19 September 2024 - 21 September 2024 Egypt
https://academicmedicaleducation.com/meeting/conference-liver-disease-africa-colda-2024
18 September 2024 - 20 September 2024 Liverpool, United Kingdom
https://academicmedicaleducation.com/meeting/international-workshop-clinical-pharmacology-hiv-hepatitis-and-other-antiviral-drugs-2024
https://www.iasociety.org/conferences/hivr4p2024/registration
https://idweek.org/#
24 October 2024 - 25 October 2024 United States
Washington DC, United States
https://academicmedicaleducation.com/meeting/international-workshop-hiv-aging-2024
10-13 November 2024
https://hivglasgow.org/
San Diego, California
https://www.aasld.org/liver-meeting-tlm-2024
https://informedhorizonseducation.com/hiv-respidart-2024